{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:16:01Z","timestamp":1771258561704,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FEDER\u2014Fundo Europeu de Desenvolimento Regional through the COMPETE 2020\u2014Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["LA\/P\/0053\/2020"],"award-info":[{"award-number":["LA\/P\/0053\/2020"]}]},{"name":"FEDER\u2014Fundo Europeu de Desenvolimento Regional through the COMPETE 2020\u2014Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"FCT and FEDER (European Union)","award":["LA\/P\/0053\/2020"],"award-info":[{"award-number":["LA\/P\/0053\/2020"]}]},{"name":"FCT and FEDER (European Union)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JFB"],"abstract":"<jats:p>This study explores the effectiveness of the antineoplastic agent 5-FU in cancer cells by leveraging the unique properties of cationic antimicrobial peptides (CAMPs) and cell-penetrating peptides (CPPs). Traditional anticancer therapies face substantial limitations, including unfavorable pharmacokinetic profiles and inadequate specificity for tumor sites. These drawbacks often necessitate higher therapeutic agent doses, leading to severe toxicity in normal cells and adverse side effects. Peptides have emerged as promising carriers for targeted drug delivery, with their ability to selectively deliver therapeutics to cells expressing specific receptors. This enhances intracellular drug delivery, minimizes drug resistance, and reduces toxicity. In this research, we comprehensively evaluate the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of various AMPs and CPPs to gain insights into their potential as anticancer agents. The peptide synthesis involved a solid-phase synthesis using a Liberty Microwave Peptide Synthesizer. The peptide purity was confirmed via LC-MS and HPLC methods. For the ADMET screening, computational tools were employed, assessing parameters like absorption, distribution, metabolism, excretion, and toxicity. The cell lines A549 and UM-UC-5 were cultured and treated with 5-FU, CAMPs, and CPPs. The cell viability was measured using the MTT assay. The physicochemical properties analysis revealed favorable drug-likeness attributes. The peptides exhibited potential inhibitory activity against CYP3A4. The ADMET predictions indicated variable absorption and distribution characteristics. Furthermore, we assessed the effectiveness of these peptides alone and in combination with 5-FU, a widely used antineoplastic agent, in two distinct cancer cell lines, UM-UC-5 and A549. Our findings indicate that CAMPs can significantly reduce the cell viability in A549 cells, while CPPs exhibit promising results in UM-UC-5 cells. Understanding these multifaceted effects could open new avenues for antiviral and anticancer research. Further, experimental validation is necessary to confirm the mechanism of action of these peptides, especially in combination with 5-FU.<\/jats:p>","DOI":"10.3390\/jfb14120565","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T05:23:22Z","timestamp":1702358602000},"page":"565","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["New Perspective for Using Antimicrobial and Cell-Penetrating Peptides to Increase Efficacy of Antineoplastic 5-FU in Cancer Cells"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"first","affiliation":[{"name":"PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5370-9586","authenticated-orcid":false,"given":"Eduarda","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"ICBAS\u2014School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"given":"In\u00eas","family":"Cruz","sequence":"additional","affiliation":[{"name":"PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"}]},{"given":"Valentina","family":"Stulberg","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biochemistry, Freie Universit\u00e4t Berlin, Arnimallee 20, 14195 Berlin, Germany"}]},{"given":"Beate","family":"Koksch","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biochemistry, Freie Universit\u00e4t Berlin, Arnimallee 20, 14195 Berlin, Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-5874","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Costa","sequence":"additional","affiliation":[{"name":"PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"De Martini, L.B., Sulmona, C., Brambilla, L., and Rossi, D. (2023). Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs. Cells, 12.","DOI":"10.3390\/cells12121643"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.addr.2021.05.010","article-title":"Peptide-Based Supramolecular Hydrogels for Local Drug Delivery","volume":"174","author":"Zhang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2017.02.006","article-title":"Recent Developments in Anticancer Drug Delivery Using Cell Penetrating and Tumor Targeting Peptides","volume":"250","author":"Dissanayake","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled Drug Delivery Vehicles for Cancer Treatment and Their Performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Li, C.M., Haratipour, P., Lingeman, R.G., Perry, J.J.P., Gu, L., Hickey, R.J., and Malkas, L.H. (2021). Novel Peptide Therapeutic Approaches for Cancer Treatment. Cells, 10.","DOI":"10.3390\/cells10112908"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lindberg, J., Nilvebrant, J., Nygren, P.-\u00c5., and Lehmann, F. (2021). Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy. Molecules, 26.","DOI":"10.3390\/molecules26196042"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-Penetrating Peptides: From Basic Research to Clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.tips.2021.07.001","article-title":"Peptide\u2013Drug Conjugate-Based Novel Molecular Drug Delivery System in Cancer","volume":"42","author":"Zhu","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e822","DOI":"10.1002\/ctm2.822","article-title":"The Role of Cell-penetrating Peptides in Potential Anti-cancer Therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jconrel.2020.05.030","article-title":"A Peptide for Transcellular Cargo Delivery: Structure-Function Relationship and Mechanism of Action","volume":"324","author":"Komin","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ghaly, G., Tallima, H., Dabbish, E., ElDin, N.B., El-Rahman, M.K.A., Ibrahim, M.A.A., and Shoeib, T. (2023). Anti-Cancer Peptides: Status and Future Prospects. Molecules, 28.","DOI":"10.3390\/molecules28031148"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yang, M., Liu, S., and Zhang, C. (2023). Antimicrobial Peptides with Antiviral and Anticancer Properties and Their Modification and Nanodelivery Systems. Curr. Res. Biotechnol., 5.","DOI":"10.1016\/j.crbiot.2023.100121"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tornesello, A.L., Borrelli, A., Buonaguro, L., Buonaguro, F.M., and Tornesello, M.L. (2020). Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities. Molecules, 25.","DOI":"10.3390\/molecules25122850"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lyu, Z., Yang, P., Lei, J., and Zhao, J. (2023). Biological Function of Antimicrobial Peptides on Suppressing Pathogens and Improving Host Immunity. Antibiotics, 12.","DOI":"10.3390\/antibiotics12061037"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"R\u0103ileanu, M., and Bacalum, M. (2023). Cancer Wars: Revenge of the AMPs (Antimicrobial Peptides), a New Strategy against Colorectal Cancer. Toxins, 15.","DOI":"10.3390\/toxins15070459"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1039\/D1TB02617H","article-title":"Antimicrobial Peptide-Based Materials: Opportunities and Challenges","volume":"10","author":"Rai","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"819563","DOI":"10.3389\/fonc.2022.819563","article-title":"Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside","volume":"12","author":"Jafari","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3892\/br.2016.639","article-title":"Cell-Penetrating Peptides: Possible Transduction Mechanisms and Therapeutic Applications","volume":"4","author":"Guo","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104475","DOI":"10.1016\/j.jddst.2023.104475","article-title":"Penetrating Peptides: Applications in Drug Delivery","volume":"84","author":"Xu","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e05948","DOI":"10.1016\/j.heliyon.2021.e05948","article-title":"Drug Combination and Repurposing for Cancer Therapy: The Example of Breast Cancer","volume":"7","author":"Correia","year":"2021","journal-title":"Heliyon"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gilad, Y., Gellerman, G., Lonard, D.M., and O\u2019Malley, B.W. (2021). Drug Combination in Cancer Treatment\u2014From Cocktails to Conjugated Combinations. Cancers, 13.","DOI":"10.3390\/cancers13040669"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming Cancer Therapeutic Bottleneck by Drug Repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Vale, N., Pereira, M., Santos, J., Moura, C., Marques, L., and Duarte, D. (2022). Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010069"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Duarte, D., and Vale, N. (2021). Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111984"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"giac087","DOI":"10.1093\/gigascience\/giac087","article-title":"SYNPRED: Prediction of Drug Combination Effects in Cancer Using Different Synergy Metrics and Ensemble Learning","volume":"11","author":"Preto","year":"2022","journal-title":"Gigascience"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer Chemotherapy and beyond: Current Status, Drug Candidates, Associated Risks and Progress in Targeted Therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jgar.2019.04.018","article-title":"Potent Cationic Antimicrobial Peptides against Mycobacterium Tuberculosis in Vitro","volume":"19","author":"Silva","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/AAC.00175-13","article-title":"Targeting Mycobacterium Tuberculosis and Other Microbial Pathogens Using Improved Synthetic Antibacterial Peptides","volume":"57","author":"Mikut","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","unstructured":"(2023, September 04). Available online: https:\/\/admetmesh.scbdd.com\/."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: An Integrated Online Platform for Accurate and Comprehensive Predictions of ADMET Properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_31","unstructured":"Ghosh, J., Lawless, M.S., Waldman, M., Gombar, V., and Fraczkiewicz, R. (2016). Silico Methods for Predicting Drug Toxicity, Humana."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/dmd.121.000552","article-title":"Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work","volume":"50","author":"Terelius","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cbpa.2017.04.012","article-title":"Cyclic Peptide Natural Products Chart the Frontier of Oral Bioavailability in the Pursuit of Undruggable Targets","volume":"38","author":"Naylor","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Doll, C., Bestendonk, C., Kreutzer, K., Neumann, K., Pohrt, A., Trzpis, I., Koerdt, S., Dommerich, S., Heiland, M., and Raguse, J.-D. (2021). Prognostic Significance of Estrogen Receptor Alpha in Oral Squamous Cell Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13225763"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"643870","DOI":"10.3389\/fendo.2021.643870","article-title":"The Role of Estrogen Receptors in Urothelial Cancer","volume":"12","author":"Goto","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41419-022-04514-4","article-title":"Estrogen Receptor Beta Promotes Lung Cancer Invasion via Increasing CXCR4 Expression","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12967-019-2056-3","article-title":"Estrogen Receptors Promote NSCLC Progression by Modulating the Membrane Receptor Signaling Network: A Systems Biology Perspective","volume":"17","author":"Gao","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Balraj, S., Selvam, P., Pommier, Y., Metifiot, M., Christophe, M., Pannecouque, C., and De Clercq, E. (2014). Investigation of Anti-HIV Activity, Cytotoxicity and HIV Integrase Inhibitory Activity of Polyherbal Formulation BH Extracts. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-S3-O23"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sala, M., Spensiero, A., Esposito, F., Scala, M.C., Vernieri, E., Bertamino, A., Manfra, M., Carotenuto, A., Grieco, P., and Novellino, E. (2016). Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00845"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10989-018-9673-1","article-title":"Development and Evaluation of Peptide-Functionalized Gold Nanoparticles for HIV Integrase Inhibition","volume":"25","author":"Singh","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"ofac029","DOI":"10.1093\/ofid\/ofac029","article-title":"Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting","volume":"9","author":"Greenberg","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/acsinfecdis.0c00819","article-title":"HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants","volume":"7","author":"Smith","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/JCRP.JCRP_10_19","article-title":"Future of 5-Fluorouracil in Cancer Therapeutics, Current Pharmacokinetics Issues and a Way Forward","volume":"6","author":"Iqbal","year":"2019","journal-title":"J. Cancer Res. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1021\/nn202452c","article-title":"Selenium Nanoparticles as a Carrier of 5-Fluorouracil to Achieve Anticancer Synergism","volume":"6","author":"Liu","year":"2012","journal-title":"ACS Nano"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1039\/D0BM01904F","article-title":"Cetuximab Functionalization Strategy for Combining Active Targeting and Antimigration Capacities of a Hybrid Composite Nanoplatform Applied to Deliver 5-Fluorouracil: Toward Colorectal Cancer Treatment","volume":"9","author":"Chen","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Samec, T., Boulos, J., Gilmore, S., Hazelton, A., and Alexander-Bryant, A. (2022). Peptide-Based Delivery of Therapeutics in Cancer Treatment. Mater. Today Bio, 14.","DOI":"10.1016\/j.mtbio.2022.100248"}],"container-title":["Journal of Functional Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4983\/14\/12\/565\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:37:14Z","timestamp":1760132234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4983\/14\/12\/565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["jfb14120565"],"URL":"https:\/\/doi.org\/10.3390\/jfb14120565","relation":{},"ISSN":["2079-4983"],"issn-type":[{"value":"2079-4983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]}}}